SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-20-000871
Filing Date
2020-01-21
Accepted
2020-01-21 16:47:09
Documents
31

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 3657277
2 ex10-17.htm EX-10.17 229061
3 ex10-38.htm EX-10.38 2152
4 ex10-38_001.jpg GRAPHIC 98143
5 ex10-38_002.jpg GRAPHIC 67168
6 ex23-1.htm EX-23.1 6211
7 ex23-1_001.jpg GRAPHIC 4736
8 ex23-1_002.jpg GRAPHIC 22092
9 logo_001.jpg GRAPHIC 7222
10 drs_012.jpg GRAPHIC 21867
11 drs_014.jpg GRAPHIC 69315
12 image_057.jpg GRAPHIC 205150
13 drs_002.jpg GRAPHIC 19365
14 chart_001.jpg GRAPHIC 22639
15 chart_002.jpg GRAPHIC 16401
16 chart_003.jpg GRAPHIC 10887
17 drs_004.jpg GRAPHIC 41195
18 drs_005.jpg GRAPHIC 41040
19 drs_018.jpg GRAPHIC 21867
20 drs_019.jpg GRAPHIC 41560
21 image_012.jpg GRAPHIC 30289
22 image_019.jpg GRAPHIC 50123
23 image_021.jpg GRAPHIC 90062
24 image_022.jpg GRAPHIC 60734
25 image_027.jpg GRAPHIC 40094
26 image_028.jpg GRAPHIC 71239
27 image_056.jpg GRAPHIC 63223
28 drs_013.jpg GRAPHIC 68810
29 logo_002.jpg GRAPHIC 14035
30 report_001.jpg GRAPHIC 1784
31 finance_001.jpg GRAPHIC 14035
  Complete submission text file 0001493152-20-000871.txt   5572134
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: F-1/A | Act: 33 | File No.: 333-234292 | Film No.: 20536814
SIC: 2834 Pharmaceutical Preparations